Table 4 Details of the patients with BOOP syndrome (n = 16)
Patient no. | Endocrine therapy | CT | Lung V20(%) | Time after RT (mo) | Symptoms | Treatment | |
|---|---|---|---|---|---|---|---|
1 | BCT | TAM | - | 7.9 | 7.6 | cough | antitussive, |
LHRH-agonist | antibiotic | ||||||
2 | BCT | TAM | - | 6.0 | 4.0 | cough, pyrexia, | steroid, |
decreased SpO2 | antibiotic | ||||||
3 | BCT | TAM | - | 5.0 | 5.3 | cough, pyrexia, | antitussive, |
fatigue | antibiotic | ||||||
4 | BCT | TAM | - | 8.6 | 5.1 | cough, pyrexia | antitussive, |
antibiotic | |||||||
5 | BCT | TAM | - | 8.1 | 2.3 | cough | antitussive, |
steroid | |||||||
6 | BCT | ANA | - | 4.4 | 5.0 | cough, fatuigue | antibiotic |
7 | BCT | ANA | - | 6.0 | 4.7 | cough | antitussive, |
antibiotic | |||||||
8 | BCT | ANA | - | 5.1 | 3.0 | cough, pyrexia | antitussive |
9 | BCT | ANA | - | 9.0 | 4.5 | cough | antitussive, |
antibiotic | |||||||
10 | BCT | ANA | - | 4.8 | 3.1 | cough, fatigue | antitussive, |
antibiotic | |||||||
11 | BCT | ANA | AC | 6.8 | 8.6 | cough | antitussive |
PAC | |||||||
12 | BCT | - | CAF | 5.6 | 6.0 | cough | antibiotic |
13 | PMRT | TAM | CAF | 17.7 | 3.3 | cough, pyrexia | antitussive, |
PAC | antibiotic | ||||||
14 | PMRT | ANA | CAF | 13.4 | 7.4 | cough | antitussive, |
PAC | antibiotic | ||||||
15 | PMRT | - | CAF | 15.6 | 3.9 | cough, pyrexia | antibiotic |
PAC | |||||||
16 | PMRT | - | CAF | 22.0 | 5.3 | cough, pyrexia, | antitussive |
PAC | fatigue |